• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

EU antitrust regulators to rule on Novo’s Catalent buy by Dec. 6

by November 4, 2024
written by November 4, 2024

By Foo Yun Chee and Maggie Fick

BRUSSELS/LONDON (Reuters) -EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings’ acquisition of contract drug manufacturer Catalent (NYSE:CTLT), according to a filing on the European Commission website on Monday.

The controlling shareholder of Novo Nordisk (NYSE:NVO) put in a request for EU approval for the deal on Oct. 31, the filing showed.

The EU antitrust regulators can either clear the deal with or without remedies, or it can open a full-scale four-month long investigation if it has serious concerns.

The acquisition, announced in February, underscores Danish drugmaker Novo Nordisk’s push to boost output of its popular obesity drug Wegovy.

Novo Holdings, Novo Nordisk and Catalent have all recently reiterated their expectations that the transaction will close towards the end of this year. The three companies did not immediately respond to a request for comment on Monday morning.

In May, the companies said they had received a second request from the U.S. Federal Trade Commission for more information on the deal. There has been no update from the FTC on its review of the deal since then.

Pharmaceuticals giant Roche said last month that regulators should block the deal on concerns that it could hit competition in the booming weight-loss drug industry. Eli Lilly (NYSE:LLY), Novo’s main rival in the obesity and diabetes drug market, has also expressed worries.

The deal has also been criticised by U.S. consumer groups, who last month urged the FTC to block it, saying it threatens competition in the booming weight-loss drug industry. Last month, U.S. Senator Elizabeth Warren asked the FTC to scrutinise the deal, saying it may give Novo Nordisk an unlawful advantage in obesity drugs.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Earnings call: ICBC reports stable growth amid market challenges
next post
Election results don’t end bull markets, S&P 500 could hit 6,500, Evercore says

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!








    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • China outlines more controls on exports of rare earths and technology

      October 10, 2025
    • Paramount acquires Bari Weiss’ The Free Press, naming her the top editor of CBS News

      October 7, 2025
    • YouTube to pay $24 million to settle Trump lawsuit

      October 1, 2025
    • Charlie Javice sentenced to 7 years in prison for fraudulent $175M sale of aid startup

      October 1, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (651)
    • Stock (6,426)

    Latest News

    • China outlines more controls on exports of rare earths and technology
    • Paramount acquires Bari Weiss’ The Free Press, naming her the top editor of CBS News

    Popular News

    • Crisis-era regulation has ‘gone too far’, Reeves tells UK finance sector
    • Citadel’s Griffin says he has not supported Donald Trump for president

    About The Significant deals

    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy